Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Initial results show Ethyol effective in reducing radiation-induced xerostomia

Nov. 3, 1997

Promising interim safety and efficacy data reported for Gd-Tex

Nov. 3, 1997

First oral, tumor-activated anticancer drug filed by Roche

Oct. 31, 1997

Temozolomide: phase II efficacy and tolerability data in patients with high-grade glioma

Oct. 31, 1997

Takeda discovers new Taxol-like compound

Oct. 31, 1997

HMR discloses azasteroids for estrogen/androgen-mediated disorders

Oct. 31, 1997

IntraBiotics codevelops IB-367 with Pharmacia & Upjohn

Oct. 31, 1997

Angiogenesis-inhibitory peptides available for licensing from NIH

Oct. 31, 1997

BE-52440A and BE-52440B: novel antitumor antibiotics reported in patent literature

Oct. 31, 1997

Inflammatory and angiogenic protein-related technology available for licensing

Oct. 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 25, 2025.
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 24, 2025
Clots and metastasis in cancer patients start in the lung
BioWorld MedTech
The lung and thrombosis may play a key role in cancer and metastasis progression, according to a collaborative study led by Cornell University scientists. In the...
Evo 2 AI allows genome and epigenome modeling of all life domains
BioWorld MedTech
A new version of Evo, the AI developed at the Arc Institute that can be used to design genomes as long as that of a bacterium, has been retrained with the DNA...